HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
Metrics to compare | HMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.3x | −1.8x | −0.5x | |
PEG Ratio | −0.20 | 0.09 | 0.00 | |
Price/Book | 54.6x | 2.7x | 2.6x | |
Price / LTM Sales | 117.8x | 2.2x | 3.2x | |
Upside (Analyst Target) | 144.4% | 87.3% | 45.6% | |
Fair Value Upside | Unlock | 17.2% | 5.3% | Unlock |